GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Honz Pharmaceutical Co Ltd (SZSE:300086) » Definitions » Market Cap

Honz Pharmaceutical Co (SZSE:300086) Market Cap : ¥2,120.9 Mil (As of Apr. 18, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Honz Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Honz Pharmaceutical Co's share price for the quarter that ended in Sep. 2024 was ¥4.94. Honz Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 455.1 Mil. Therefore, Honz Pharmaceutical Co's market cap for the quarter that ended in Sep. 2024 was ¥2,248.3 Mil.

Honz Pharmaceutical Co's quarterly market cap declined from Mar. 2024 (¥2,286.0 Mil) to Jun. 2024 (¥1,579.5 Mil) but then increased from Jun. 2024 (¥1,579.5 Mil) to Sep. 2024 (¥2,248.3 Mil).

Honz Pharmaceutical Co's annual market cap declined from Dec. 2021 (¥3,906.0 Mil) to Dec. 2022 (¥2,799.0 Mil) and declined from Dec. 2022 (¥2,799.0 Mil) to Dec. 2023 (¥2,641.5 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Honz Pharmaceutical Co's Enterprise Value for Today is ¥2,612.2 Mil.


Honz Pharmaceutical Co Market Cap Historical Data

The historical data trend for Honz Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Honz Pharmaceutical Co Market Cap Chart

Honz Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,367.00 2,529.00 3,906.00 2,799.00 2,641.50

Honz Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,812.50 2,641.50 2,286.00 1,579.50 2,248.31

Competitive Comparison of Honz Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Honz Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Honz Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Honz Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Honz Pharmaceutical Co's Market Cap falls into.


;
;

Honz Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Honz Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥5.87*450.000
=¥2,641.5

Honz Pharmaceutical Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=¥4.94*455.124
=¥2,248.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Honz Pharmaceutical Co  (SZSE:300086) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Honz Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Honz Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Honz Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 69 Xianlie Zhonglu, 2601 26/F Dongshan Plaza, GuangDong,Province, Guangzhou, CHN, 510095
Honz Pharmaceutical Co Ltd is engaged in providing medicines for children. The company's practice in this sector mainly involves the research and development, manufacturing and sales of pediatric medicines. It has automated and intelligent manufacturing bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong.
Executives
Wang Chun Ying Supervisors
Rui Shou Hong Director
Hong Jiang You Directors, executives
Hong Zhi Hui Director
He Zi Qun Supervisors
Hong Li Ping Directors, executives
Hong Jiang Tao Director
Liu Hui Liang Executives
Hu Fei Hong Director
Li Ping Independent director
Fu Lin Jun Director

Honz Pharmaceutical Co Headlines

No Headlines